EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Therapeutic approaches and novel antifibrotic agents in renal fibrosis: A comprehensive review

Ganesh Panditrao Lahane, Arti Dhar, Audesh Bhat

Journal of Biochemical and Molecular Toxicology · 2024-08 · 38 (8)

DOI: 10.1002/jbt.23795 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 12.08.2024. Verfasst von Ganesh Panditrao Lahane und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Birla Institute of Technology and Sciences (BITS) Pilani, Hyderabad, Telangana, India. Hauptthemen laut MEDLINE: Fibrosis, Antifibrotic Agents. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 235 Literaturangaben. Gefördert von: ICMR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Renal fibrosis (RF) is one of the underlying pathological conditions leading to progressive loss of renal function and end‐stage renal disease (ESRD). Over the years, various therapeutic approaches have been explored to combat RF and prevent ESRD. Despite significant advances in understanding the underlying molecular mechanism(s), effective therapeutic interventions for RF are limited. Current therapeutic strategies primarily target these underlying mechanisms to halt or reverse fibrotic progression. Inhibition of transforming growth factor‐β (TGF‐β) signaling, a pivotal mediator of RF has emerged as a central strategy to manage RF. Small molecules, peptides, and monoclonal antibodies that target TGF‐β receptors or downstream effectors have demonstrated potential in preclinical models. Modulating the renin–angiotensin system and targeting the endothelin system also provide established approaches for controlling fibrosis‐related hemodynamic changes. Complementary to pharmacological strategies, lifestyle modifications, and dietary interventions contribute to holistic management. This comprehensive review aims to summarize the underlying mechanisms of RF and provide an overview of the therapeutic strategies and novel antifibrotic agents that hold promise in its treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibrosisAntifibrotic AgentsHumansKidney DiseasesAnimalsTransforming Growth Factor betaKidneyRenin-Angiotensin SystemSignal Transduction

Stichwörter der Autor:innen

novel antifibrotic agentsrenal fibrosissignaling pathwaystherapeutic strategies

Substanzen

Antifibrotic AgentsTransforming Growth Factor beta

Autor:innen und Institutionen

  • Department of Pharmacy, Birla Institute of Technology and Sciences (BITS) Pilani, Hyderabad, Telangana, India.
  • Centre for Molecular Biology, Central University of Jammu, Samba, Jammu and Kashmir, India.

Förderung

  • ICMR

Zitieren

APA

Lahane, G. P., Dhar, A., & Bhat, A. (2024). Therapeutic approaches and novel antifibrotic agents in renal fibrosis: A comprehensive review. Journal of Biochemical and Molecular Toxicology, 38(8). https://doi.org/10.1002/jbt.23795

Vancouver

Lahane GP, Dhar A, Bhat A. Therapeutic approaches and novel antifibrotic agents in renal fibrosis: A comprehensive review. Journal of Biochemical and Molecular Toxicology. 2024;38(8). doi:10.1002/jbt.23795

BibTeX
@article{Lahane2024,
  author = {Lahane, Ganesh Panditrao and Dhar, Arti and Bhat, Audesh},
  title = {Therapeutic approaches and novel antifibrotic agents in renal fibrosis: A comprehensive review},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2024},
  volume = {38},
  number = {8},
  doi = {10.1002/jbt.23795}
}
Kostenlos starten →